Real-time enrollment status for this group b streptococcus clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:50 AM UTC
| NCT Number | NCT07160244 |
| Recruiting Status | Recruiting |
| Condition | Group B Streptococcus |
| Phase | PHASE3 |
| Target Enrollment | 6,000 participants |
| Active Locations | 122 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | July 9, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT07160244 is currently recruiting participants. This phase3 study for group b streptococcus is actively seeking new participants at 122 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07160244 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 122 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07160244 was last updated 1 week ago (July 9, 2026). HelloStudys verifies this status automatically.